Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

A new HIV prevention drug, lenacapavir, has shown 100% effectiveness in women and near-perfect results in men during trials.

Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...

We still have 1.3 million new infections a year, the majority of which occur in marginalised and vulnerable groups. But we ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

While the rollout of highly active antiretroviral therapy (HAART) has transformed HIV from a fatal illness into a largely ...

Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to be effective.When lenacapavir test results were presented at a World AIDS ...

A new drug called Lenacapavir is nearly 100% effective in preventing and treating HIV infections. But will it be made affordable for the tens of millions of people around the world who need it?

According to a study published in the New England Journal of Medicine, twice-yearly injection of Lenacapavir offers a 96 percent ...

A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...

Aids was first identified 40 years ago: these are the game changers that have revolutionised treatment – and the obstacles ...

Discover the groundbreaking results of Lenacapavir, a twice-yearly injection that reduces HIV infection risk offering an ...